Patent 9867822 was granted and assigned to Arena Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;